Embla Medical hf Management
Management criteria checks 3/4
Embla Medical hf's CEO is Sveinn Solvason, appointed in Apr 2022, has a tenure of 2.5 years. total yearly compensation is $1.18M, comprised of 48.8% salary and 51.2% bonuses, including company stock and options. directly owns 0.016% of the company’s shares, worth $324.19K. The average tenure of the management team and the board of directors is 2.5 years and 15.8 years respectively.
Key information
Sveinn Solvason
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 48.8% |
| CEO tenure | 2.5yrs |
| CEO ownership | 0.02% |
| Management average tenure | 2.5yrs |
| Board average tenure | 15.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$61m |
| Mar 31 2024 | n/a | n/a | US$57m |
| Dec 31 2023 | US$1m | US$576k | US$58m |
| Sep 30 2023 | n/a | n/a | US$52m |
| Jun 30 2023 | n/a | n/a | US$45m |
| Mar 31 2023 | n/a | n/a | US$43m |
| Dec 31 2022 | US$780k | US$409k | US$43m |
Compensation vs Market: Sveinn's total compensation ($USD1.18M) is below average for companies of similar size in the US market ($USD5.57M).
Compensation vs Earnings: Sveinn's compensation has increased by more than 20% in the past year.
CEO
Sveinn Solvason (46 yo)
2.5yrs
Tenure
US$1,180,000
Compensation
Mr. Sveinn Solvason had been Chief Financial Officer of Embla Medical hf. (formerly known as ssur hf.) since May 2013 until April 1, 2022 and serves as its President & CEO since April 1, 2022.Mr. Solvaso...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & CEO | 2.5yrs | US$1.18m | 0.016% $ 324.2k | |
| Founder | no data | US$25.00k | no data | |
| Chief Financial Officer | 2.1yrs | no data | no data | |
| Chief Operating Officer | 1.3yrs | no data | no data | |
| Investor Relations Director | no data | no data | no data | |
| Executive Vice President of People | no data | US$242.00k | 0.0083% $ 167.9k | |
| Chief Commercial Officer | no data | US$600.00k | 0.0030% $ 60.7k | |
| Executive Vice President of EMEA & APAC | 6.9yrs | no data | 0.023% $ 465.1k | |
| President of Americas | no data | no data | 0.0031% $ 62.6k | |
| Executive Vice President of Research & Development | 2.5yrs | no data | 0.00014% $ 2.8k |
2.5yrs
Average Tenure
50yo
Average Age
Experienced Management: OSSU.Y's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 19.8yrs | US$108.00k | 0.048% $ 964.5k | |
| Vice Chairman of the Board | 16.8yrs | US$72.00k | no data | |
| Independent Director | 11.6yrs | US$43.00k | 0.0062% $ 124.7k | |
| Director | 15.8yrs | US$50.00k | no data | |
| Independent Director | 3.6yrs | US$43.00k | no data |
15.8yrs
Average Tenure
67yo
Average Age
Experienced Board: OSSU.Y's board of directors are seasoned and experienced ( 15.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/10/08 10:16 |
| End of Day Share Price | 2024/07/11 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Embla Medical hf. is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Morten Larsen | ABG Sundal Collier |
| Benjamin Silverstone | ABG Sundal Collier Sponsored |
| null null | ABG Sundal Collier Sponsored |